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fd. Note - This overview was originally presented at the 
International Symposium on Clinical Disorders of Bone 
and Mineral Metabolism, May 9-13, 1983. The following 
list indicates the presentations given in this session at the 
Symposium and the contents ofthe corresponding chap-
ter in the Proceedings of the Symposium published by 
Excerpta Medica. The numbers in parentheses refer to 
pages in this volume. Complete information about the 
contents ofthe Proceedings can be found at the back of 
this issue. 
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Bone disease in patients receiving total parenteral nutr i -
t ion. S.M. Ott , N.A. Maloney, G.L. Klein, A.C. Alfrey, 
M.E. Ament, J.W. Coburn, and D.J. Sherrard (237) 
The pathogenesis of tumor- induced osteomalacia: A 
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M.K. Drezner (242) 
Recen t advances in laboratory methods and techniques 
related to bone and mineral metabolism have provided a 
detailed study of factors important in bone formation. 
Osteomalacia results from a disturbance in mineraliza-
t ion of bone matrix. Theoretically, bone matrix may fail 
to mineralize because of abnormalities in collagen and 
matrix proteins, or because of an alteration in mineral 
metabolism at the mineralization front. The result is an 
accumulation of increased quantities of unmineralized 
bone matrix (osteoid) over bone surfaces. 
Rickets is more apparent in children who have otherwise 
normal growth patterns, including that of the cartilage 
present in the growth plates of long bones. Likewise, 
osteomalacia is less apt to occur when normal bone 
matrix formation is deficient. In order for a defect in 
bone mineralization to be fully expressed, adequate 
bone matrix must first be deposited. 
The Table lists some of the factors currently considered 
to be possibly significant in the formation of bone matrix 
and mineralization. 
Recent studies suggest that bone resorption itself may be 
important as an initiating event for osteoblast formation 
and funct ion in the bone remodeling unit (BMU). A high 
molecular weight polypeptide which has been isolated 
f rom tissue cultures and demineralized human bone 
matrix, stimulates osteoblast proliferation and matrix 
format ion. Impaired release or other defect in this cou-
pling or skeletal growth factor could theoretically inf lu-
ence subsequent osteoblast vigor and function. 
Collagen synthesis is the initial, major component of 
bone matrix formation. Maturation of collagen, which 
appears to be important for mineralization, is character-
ized by increasing intra- and extrafibrillar cross-linking 
of collagen fibers. Some defects in mineralization may 
result f rom an abnormality in collagen structure. For 
instance, in the rare skeletal disorder known as f ibro-
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genesis imperfecta ossium, marked distortion of the 
normally polarized collagen fibers appears to result in 
impaired mineralization and increased numbers of 
widened osteoid seams. 
The chronologic age of the person as well as the age of 
the osteoblasts may influence the rate and extent of 
matrix formation. Decreases in the matrix appositional 
rate correlates with age and distance from the cement 
line in individual BMUs. Only insulin and growth hor-
mone, the latter via somatomedin, directly stimulate 
bone collagen synthesis. Other hormones primarily play 
a modulating role in collagen formation. 
Recently, noncollagenous bone matrix proteins have 
been evaluated as possible causes of defective minerali-
zation. Osteocalcin (gla protein) has been extensively 
studied, but its ultimate role in bone metabolism is still to 
be determined. Osteocalcin has an affinity for binding to 
hydroxyapatite but only after the latter's maturation 
from an initial amorphous mineral phase. Another bone 
matrix protein, osteonectin appears to facilitate the 
nucleation of calcium phosphate mineral onto the sur-
face of type I collagen. 
Proteoglycans and glycoproteins are other important 
extracollagenous proteins in bone matrix. Whi le their 
role in mineralization needs further clarification, they do 
have a high binding affinity for calcium, which appar-
ently depends on the presence of a large number of free 
acidic groups. Theoretically, excessive calcium binding 
to proteoglycans might interfere with normal mineral 
deposition at the mineralization front. In fact, certain 
rare forms of osteomalacia may be related to a defect in 
concentration or function of one or more of the matrix 
proteins. One form of osteomalacia that could result 
from such a defect is axial osteomalacia. In this skeletal 
affl iction, osteomalacia of the axial skeleton (exhibiting a 
coarsened trabecular pattern on skeletal x-rays) is not 
associated with any obvious disturbance in mineral or 
vitamin D metabolism. An abnormality in one of the 
extracollagenous matrix proteins could account for this 
mineralization defect. 
Because methods of study are available, most identif ied 
forms of osteomalacia have been related to disturbances 
in mineral and vitamin D metabolism. After appropriate 
maturation of bone matrix overa period of 10 to 15 days, 
primary mineralization occurs, and about 80% of the 
mineral is deposited in the first few days. This primary 
mineralization is largely control led by the osteoblasts 
and nearby osteoid osteocytes. The remainder of the 
mineral is deposited at a slower rate over a six-month 
period or more, a process known as secondary minerali-
zation. Osteoblast influence is less important in this lat-
ter phase of mineral deposition. 
A number of precisely t imed chemical and physiological 
factors must interact for mineralization to proceed nor-
mally. Ambient concentrations of calcium and particu-
larly of phosphate are important. Since osteomalacia 
occurs in many patients with chronic hypophosphate-
mia, other modulating factors are also important. In this 
section, M.C. de Vernejoul and associates (pp. 232 ff.) 
report on 19 male patients with chronic hypophos-
phatemia due to a renal phosphate leak independent of 
parathyroid hormone. Whilethere was noosteoid accum-
ulation, decreased osteoblast appositional rate was never-
theless present. As in rickets, normal growth of bone 
matrix may be necessary before a mineralization defect 
can be fully expressed. 
Relatives of patients with X-linked hypophosphatemic 
rickets and osteomalacia may exhibit hypophosphate-
mia wi thout apparent bone involvement. However, 
many of these patients have not had careful bone biopsy 
studies with current histomorphometr ic techniques to 
exclude a defect in mineralization. Chronic hypocalce-
mia appears to result in rickets and osteomalacia only 
TABLE 
Factors Inf luencing Bone Matr ix 
Formation and Mineral izat ion 
Bone resorption in bone remodel ing units (BRUs) 
• Release of a coupl ing factor that stimulates osteoblasts 
Osteoblast funct ion 
• Collagen format ion and maturation 
1. Chronologic age of person 
2. Insulin 
3. Growth hormone (via somatomedin) 
• Bone matrix proteins 
1. Osteocalcin (Gla protein) 
2. Osteonectin 
3. Proteoglycans 
Mineral izat ion at the mineralization front 
• Ambient Ca, PO^ concentrations 
• pH at mineralization front 
• Amorphous Ca, PO.,(ACP) preceding 
hydroxyapatite formation (?) 
• Vitamin D metabolites 
1. Maintain adequate ambient Ca, PO,, levels 
2. (?) Direct effect on osteoblasts and/or mineralization front 
• Parathyroid hormone 
• Piezoelectric fields (exercise and stress) 
• Inhibitors of mineralization 
1. Pyrophosphates ) destroyed by 
2. ATP (adenosine triphosphate) V phosphatases 
3. Foreign ions, such as a luminum \ and ATPases 
• Matr ix vesicles 
1. Facilitates mineral and enzyme concentrat ion at the 
mineralization front 
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rarely. Examples are seen primarily in rapidly growing 
children who have subsisted on a calcium deficient diet. 
Hydrogen ion concentration appears to bean important 
clinical factor at the mineralization front. Chronic sys-
temic acidosis, as occurs in patients who have under-
gone ureterosigmoidostomy, can result in osteomala-
cia, even in the presence of normal serum levels of 
calcium and phosphorus. 
Most theories of calcification suggest that crystalline 
hydroxyapatite is preceded by an amorphous noncrystal-
line calcium phosphate complex, although recent studies 
have questioned the validity of this concept. 
The role of several vitamin D metabolites in bone miner-
alization is discussed extensively elsewhere in this Pro-
ceedings. The importance of these metabolites in main-
taining adequate serum concentrations of calcium and 
phosphorus is unquestioned. Whether they have an 
additional direct effect on osteoblasts or on mineraliza-
t ion is hotly debated. 
Parathyroid hormone appears to directly affect or 
enhance the availability of minerals at the mineraliza-
t ion front. In some patients with renal osteodystrophy 
decreased parathyroid funct ion appearsto increase the 
tendency toward a form of osteomalacia that resists the 
usual treatment. 
Exercise by initiating shearing forces on mineral crystals 
induces electrical fields (piezoelectrical) that may inf lu-
ence bone format ion. Fracture non-union is now being 
successfully treated in some instances by application of 
low-grade pulsed electrical currents. The importance of 
such electrical fields in the process of normal matrix 
formation and mineralization may be important but is 
difficult to prove. 
Just as important as the factors that enhance mineraliza-
tion of bone matrix are the inhibitors of mineralization 
that have been identif ied in bone. Both pyrophosphates 
and ATP are known to impede different phases of mineral 
formation and deposition, and removing these inhibitors 
by endogenous pyrophosphatases (phosphatases) and 
ATPases encourages mineralization. In hypophosphata-
sia, a condit ion with a deficiency of alkaline phosphatase 
and an increase in the inhibitor phosphoethanolamine, 
mineralization inhibitors may play an important role in 
the development of rickets and osteomalacia. 
Much current investigation is centered on the role of 
matrix vesicles in mineralization of cartilage and bone 
matrix. These structures are detected by ultrastructural 
examination at mineralizing sites in cartilage and bone. 
They consist of membrane-bound concentrations of 
minerals and enzymes, appearing at the initial site of 
mineral deposition. 
Bone matrix formation and its mineralization is a complex 
process, and many possibilities exist for metabolic defects 
which may lead to impaired mineralization. Further use 
of electron spectroscopic imaging, as described by Arse-
nault and associates (pp. 220 ff.) should help define the 
factors important for mineral deposition. These authors 
demonstrated that an increased concentration of alumi-
num at the zone of calcification in the growth plate 
retards normal mineralization in aluminum-treated rats. 
Other studies have demonstrated the importance of 
aluminum in inhibit ing mineralization, both in the treat-
ment resistant osteomalacia observed in hemodialysis 
patients with renal osteodystrophy and in patients who 
have been maintained on total parenteral nutrit ion. The 
use of electron probes in association with histochemical 
techniques offers promise in the study of the mineraliza-
tion process. One day we may have a detailed map of the 
osteoid seam, where the concentrations of all important 
factors needed for normal mineralization can be meas-
ured, and variations from normal can be detected. 
Bone histomorphometry with the use of double tetracy-
cline labeling techniques and undecalcified bone sec-
tions has come of age. An absence of osteomalacia, or at 
the other extreme, f lorid osteomalacia, can readily be 
identified by most established calcified tissue laborato-
ries. However, there is less agreement on criteria for the 
earliest histomorphometric signs of osteomalacia, espe-
cially when accompanied by secondary hyperparathyroid-
ism. International agreement should be sought in estab-
lishing histodynamic criteria foral l stages of osteomalacia 
so that studies from different clinical research centers can 
be compared more readily. Rao and others (pp. 224 ff.) in 
Parfitt's laboratory at Henry Ford Hospital addressed this 
problem. As kinetic criteria in making the diagnosis of 
osteomalacia, these investigators use a mean osteoid 
seam width of greater than 15.0/ym and a mineralization 
lag t ime of greater than 100 days. They stressed that the 
early effects of hypovitaminosis D are mainly those of 
secondary hyperparathyroidism. As vitamin D deficient 
osteopathy progresses, the mineralization defect becomes 
more apparent, with a progressive accumulation of osteoid. 
Metabolic bone disease is a common problem in patients 
with chronic liver disease. Patients with chronic biliary 
tract obstruction are more likely to have osteomalacia 
and patients with chronic diffuse hepatocellular disease 
are more likely to have osteoporosis. I mportant etiologic 
factors are defective vitamin D and 25 hydroxyvitamin D 
absorption, impaired synthesis of 25 hydroxyvitamin D, 
the deleterious effects of chronic alcoholism on the skel-
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eton, hypoproteinemia, and other i l l-defined nutritional 
deficiencies. In view of this, the findings of Recker and 
associates (pp. 227 ff.) in patients with primary biliary and 
alcoholic cirrhosis were somewhat surprising. They found 
no evidence of vitamin D deficiency or osteomalacia, 
and bone histologic changes in both groups of patients 
were indistinguishable from those patients with post-
menopausal osteoporosis. 
Much work still needs to be done to determine the 
pathogenesis of the bone disease in patients with chronic 
liver disorders. The type, degree, and duration of liver 
disease needs to be correlated with defects in mineral 
and vitamin D metabolism as well as with histomorpho-
metric changes in the skeleton. The results of Recker and 
associates are discouraging with respect to the possibility 
of effective treatment in patients with metabolic bone 
disease due to chronic liver failure, no matter what the 
underlying etiology. 
Many believe that sporadic hypophosphatemic osteo-
malacia in the adult is almost always related toan under-
lying tumor, usually mesenchymal. Such tumors may be 
quite small and diff icult to detect, but the effort to f ind 
the m is worthwhi le, since successful removal often 
improves or cures the underlying osteomalacia. Renal 
phosphate wastage and hypophosphatemia appear to 
cause osteomalacia in such patients. 
Studies reported by Drezner and associates (pp. 242 ff.) 
shed further light on this paraneoplastic syndrome of 
tumor-induced osteomalacia. Their studies suggested 
further evidenceof a tumor-induced alteration of vitamin 
D metabolism which may cause a urinary phosphate 
leak. The tumor-producing agent that interferes with 
renal 1-hydroxylation of 25 hydroxyvitamin D has so far 
eluded identification. 
Identifiable causes of osteomalacia continue to increase. 
Notsurpr is ingly, fore ign ions deposited at the mineral-
ization f ront can interfere with normal mineral izat ion. 
Ott and associates (pp. 237 ff.) presented evidence that 
the etiology o f t he metabolic bone disease observed in 
patients receiving total parenteral nutr i t ion (TPN) is 
somewhat similar to the resistant form of osteomalacia 
observed in some patients wi th renal osteodystrophy 
who have been maintained on hemodialysis. In both 
condit ions, aluminum from exogenoussources appears 
to interfere wi th normal mineral deposit ion. Removal 
of the a luminum after the use of desferrioxamine 
allows normal matrix mineralization to be restored. In 
bone disease associated with total parenteral nut r i t ion, 
a luminum contaminat ion o f t he casein used in the TPN 
solut ion may be the culpri t . Steps should be taken to 
insure that TPN solutions do not contain a luminum or 
other potentially toxic trace elements that can impair 
normal mineral izat ion. If this approach is effective, 
perhaps the painful disabling bone disease seen in 
these patients wil l no longer be observed. However, it 
should be remembered that not all workers have had a 
similar experience wi th regard to a luminum as an et io-
logic agent in TPN bone disease. This bone disorder 
may have more than one cause. 
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